Skip to main content
Log in

SMC says `yes' to six drugs

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Scottish Medicines Consortium. SMC advice: abatacept (Orencia); argatroban (Exembol); calcium polystyrene sulphonate (Sorbisterit); chloroprocaine hydrochloride (Ampres); elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil (as fumarate) (Stribild); pirfenidone (Esbriet); ursodeoxycholic acid (Ursofalk). Internet Document : 12 Aug 2013. Available from: URL: http://www.scottishmedicines.org.uk

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

SMC says `yes' to six drugs. PharmacoEcon Outcomes News 685, 11 (2013). https://doi.org/10.1007/s40274-013-0663-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0663-4

Navigation